[
    {
        "source_PMID": "9742977",
        "questions": [
            " What are the results of this study? (Also called: Type 2 diabetes - type 2)",
            " What is (are) specific advantage or disadvantage? (Also called: Type 2 diabetes - type 2)",
            " What is (are) symptoms after 3 months' initial diet? (Also called: Diet - non-pregnant; Intensive blood-glucose control policy)",
            " What are the results of a secondary analysis comparing the 342 patients allocated metformin vs. 951 overweight patients? (Also called: Diet - diabetes-related)",
            " What causes mortality - primary sulphonylurea therapy (n=269)?",
            " What are the conclusions of this meta-analysis? (Also called: Metformin - metformin; Conventional pharmacologic therapy; Diabetes mellitus)",
            " What is (are) 42% for diabetes-related death (9-63, p=0.017), and 36% for all-cause mortality (9-55)",
            " What are the questions related to metformin-allocated patients? (Also called: Efficacy of sulphonylurea-treated patients)",
            " What is (are) patients having diabetes-related endpoints (risk reduction 19% [2-33], p=0.033)",
            " What is (are) sulphonylurea and metformin (risk reduction 5% [-33 to 32], p=0.78)",
            " What is (are) hypoglycaemic attacks - first line pharmacological therapy?"
        ]
    },
    {
        "source_PMID": "32891604",
        "questions": [
            " What are the challenges of multifactorial intervention in the management of diabetic kidney disease? (Also called: Infectious renal disease - type 2)",
            " What are the therapy treatment targets for HbA1c under 6.2%, blood pressure under 120/75 mmHg, low-density lipoprotein cholesterol under 120 mg/dL)",
            " What is (are) mg/dL) on diabetic kidney disease? (Also called: J-DOIT3)",
            " What is (are) kidney outcome measures? (Also called: baseline; progression from normoalbuminuria to macroalbuminura; median age of treatment; median survival rate of 8.5 years)",
            " What is (are) more compared to baseline, or kidney failure? (Also called: glomerular filtration rate; conventional therapy group: renal failure)",
            " What are the results of Intensive therapy and conventional therapy? (Also called: multifactorial intervention - intensive)",
            " What causes questions about multifactorial intervention?"
        ]
    },
    {
        "source_PMID": "32215272",
        "questions": [
            " What is (are) Diabetic peripheral neuropathy? (Also called: Non-pregnant diabetic neuropathy; Diabetes mellitus)",
            " What to do for Type 2 diabetes patients with peripheral neuropathy? (Also called: type 2 diabetes - resistance-aerobic)",
            " What is (are) experimental and control groups? (Also called: resistance-aerobic training; resistance training; aerobic training)",
            " What is (are) aerobic endurance - after eight weeks of combined (resistance-aerobic) training?",
            " What is (are) combined (resistance-aerobic) exercise training?",
            " What is (are) questions to ask yourself - combined exercise training?"
        ]
    },
    {
        "source_PMID": "30012135",
        "questions": [
            " What are the goals of Lithium toxicity? (Also called: NTI; Lithonate toxicity; Lithotabs toxicity)",
            " What is (are) lithium-induced mortality - nonprescription? (Also called: RCT; CKD)",
            " What is the methodology of a randomized controlled trial (RCT) to treat lithium-induced NDI?",
            " What is (are) 18-85-year-olds with indicators of NDI - atorvastatin (20 mg/day)",
            " What is (are) aquaporin excretion - 12-week follow-up?",
            " What is (are) ClinicalTrials.gov NCT02967653."
        ]
    },
    {
        "source_PMID": "31295292",
        "questions": [
            " What to do for Therapeutic footwear and future complications of diabetes? (Also called: Diabetic foot ulcer - therapeutic footwear)",
            " What is (are) Reduce the risk of plantar ulcers - rigid rocker sole?",
            " What are the results of a randomized controlled trial in a special diabetic foot unit?",
            " What is (are) - therapeutic footwear with a rigid rocker sole (experimental)",
            " What are the findings of this retrospective study? (Also called: Isocomial recurrence; Plantar fasciitis)",
            " What causes ulcer recurrence - intention-to-treat? (Also called: polyneuropathy - objective; diabetes mellitus)",
            " What is (are) time in diabetes patients with polyneuropathy and DFU history (P = 0.019; 95% confidence interval, 0.086-0.807; hazard ratio, 0.263)",
            " What causes ClinicalTrials.gov NCT02995863."
        ]
    },
    {
        "source_PMID": "32621644",
        "questions": [
            " What are the objectives of Lithium-induced NDI? (Also called: RCT; Lithonate-induced diabetes insipidus)",
            " What are the goals of lithium-induced NDI - clinical trials?",
            " What is (are) in the treatment of NDI in chronic lithium users?",
            " What are the questions about aquaporin-2 excretion at 12 weeks adjusted for baseline?",
            " What are the results of atorvastatin 20 mg/d?",
            " What causes questions about atorvastatin 20 mg/d?"
        ]
    },
    {
        "source_PMID": "32321301",
        "questions": [
            " What are the objectives of this study? (Also called: Non-proliferative diabetic retinopathy; Diabetes mellitus)",
            " What are the objectives of this prospective randomized study? (Also called: randomized controlled trial; diabetes mellitus; diabetes retinopathy)",
            " What is (are) Mellitus patients versus healthy controls?",
            " What are the results of the diabetes mellitus - control group?",
            " What are the questions related to HbA1c levels and diabetes mellitus times?",
            " What are the results of endothelial cell densitometer in diabetes mellitus patients with non-proliferative diabetic retinopathy?",
            " What is (are) Conclusive conclusions about endothelial cell density in diabetes mellitus patients? (Also called: Der(22)t(11;22)"
        ]
    },
    {
        "source_PMID": "34889293",
        "questions": [
            " What is (are) Diabetic peripheral neuropathy? (Also called: DPN)",
            " What is (are) in moxibustion therapy for diabetic amputation?",
            " What is (are) evaluate the effectiveness and safety of moxibustion therapy on diabetic peripheral neuropathy?",
            " What is (are) 2 groups (moxibustion group and waiting group)",
            " What is (are) week, whereas no intervention will be done on the waiting group.",
            " What is (are) DISCUSSION - EVALUATION OF EFFORTABILITY - 6 months (Also called: Assessment of Neuropathic Symptoms and Signs (NES))",
            " What is (are) Ankle Ability Measure, and serum HbA1c and albumin levels?"
        ]
    },
    {
        "source_PMID": "7587918",
        "questions": [
            " What causes diabetic microvascular complications - intensive glycemic control? (Also called: Non-insulin-dependent diabetes mellitus (NIDDM)",
            " What is (are) NIDDM - primary prevention cohort? (Also called: multiple insulin injection treatment group (MIT group)",
            " What is (are) retinopathy - primary-prevention cohort? (Also called: secondary-intervention cohort; second-stage renal disease)",
            " What causes the worsening of complications in this study? (Also called: retinopathy)",
            " What is (are) increase of one or more steps in 3 stages (nephropathy)",
            " What is (are) group in the primary-prevention cohort (P = 0.039; 19.2% for MIT group; 44.0% for CIT group)",
            " What is (are) 7.7% for the MIT group and 28.0% for the CIT group in the primary prevention cohort (P = 0.032)",
            " What causes questions about nerve conduction velocities - MIT group? (Also called: R-R interval; CIT group; MIT vs. CIT)",
            " What is (are) how to prevent glycemic control in Japanese patients with NIDDM?",
            " What is (are) NIDDM - threshold? (Also called: HbA1c <unk> 6.5%; FBG <unk> 7.5%)"
        ]
    },
    {
        "source_PMID": "7598463",
        "questions": [
            " What are the questions associated with Diabetes Control and Complications Trial? (Also called: IDM - intensive care; Diabetes mellitus-infused diabetic retinopathy)",
            " What is (are) hypoglycemia - intensive treatment? (Also called: non-insulin-dependent diabetes mellitus)",
            " What is (are) most patients with non-insulin-dependent diabetes mellitus? (Also called: NIDDM)"
        ]
    }
]